Electronic Identification and Trust Services for Electronic... · SCHEDULE 3

8 Human Medicines Regulations 2012

Sch. 3 para. 8 · in force: yes

Captured statutory text (L5)

8 Human Medicines Regulations 2012

(1)In regulation 8(1) (general interpretation) of the Human Medicines Regulations 2012 , after the definition “electronic communication”, insert— “electronic signature” has the meaning given within Article 3(10) of Regulation (EU) 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market; .

(2)In regulation 219(5) (electronic prescriptions) of the Human Medicines Regulations 2012, for the definition of “advanced electronic signature”, substitute— “advanced electronic signature” has the meaning given within Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market; .

Full captured verbatim text

(1) In regulation 8(1) (general interpretation) of the Human Medicines Regulations 2012 , after the definition “electronic communication”, insert—

“electronic signature” has the meaning given within Article 3(10) of Regulation (EU) 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market;

.

(2) In regulation 219(5) (electronic prescriptions) of the Human Medicines Regulations 2012, for the definition of “advanced electronic signature”, substitute—

“advanced electronic signature” has the meaning given within Article 3(11) of Regulation (EU) No 910/2014 of the European Parliament and of the Council on electronic identification and trust services for electronic transactions in the internal market;

.

What this provision means

Model summary, checked against the text on the left.

Relevance to Signicat: 2/3 · detailed summary (L4) Status: not needed for a short provision · Stored artifact; current recipe verification unavailable

Electronic signature and advanced electronic signature under human medicines and electronic prescriptions rules are defined by reference to Regulation EU 910/2014.

Only the one-line summary above is stored for this provision; the text itself is the evidence.

Refers to

other law external_cite · reg. 219

other law external_cite · reg. 8 Part 1

other law external_cite · reg. 8 Part 2

other law external_cite · reg. 8 Part 3

Referred to by

schedule ref schedule_ref · reg. 5

Part summaries

0 of 0 parts have a verified summary.

L1 unavailable for current verification: the overall summary needs every part verified. Provisions and the verified summaries remain readable.

Verification findings (75)

synthesis coverage: missing/unverified L2 part-1

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-1

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-2

synthesis coverage: missing/unverified L2 part-2

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-3

synthesis coverage: missing/unverified L2 part-3

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-4

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-5

synthesis coverage: missing evaluation uk:uksi/2016/696#regulation-6

synthesis coverage: missing/unverified L2 schedule-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-1-paragraph-11

synthesis coverage: missing/unverified L2 schedule-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-6A

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7A

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-7B

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-21

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-22

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-23

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-24

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-25

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-26

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-2-paragraph-27

synthesis coverage: missing/unverified L2 schedule-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-1

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-2

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-3

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-4

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-5

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-6

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-7

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-8

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-9

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-10

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-11

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-12

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-13

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-14

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-15

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-16

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-17

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-18

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-19

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-20

synthesis coverage: missing evaluation uk:uksi/2016/696#schedule-3-paragraph-21

Instrument tier unavailable

Change history as published

Sch. 3 para. 7 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Sch. 3 para. 17 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Sch. 3 para. 20 revoked (24.2.2025) by The Procurement Act 2023 (Consequential and Other Amendments) Regulations 2025 (S.I. 2025/163), reg. 1(2), Sch. Pt. 2

Pending effects amendments not yet applied to this text

No captured pending effects.

Provenance

Every claim the system makes about this text is traceable to these identifiers.

Instrument: uk:uksi/2016/696
Part: SCHEDULE 3
Version: d49dbc556a03966e92c4becd…
Content hash: sha256 03bac148cde1196f166b8c27…
Source: legislation.gov.uk/uksi/2016/696